In this episode, Alexa Basilio, PharmD, BCOP and Jessica Davis, PharmD, BCOP, CPP discuss immune-related adverse events and toxicities among patients using immune checkpoint inhibitors. This overview will include discussion about: 

  • How and when to monitor and treat mild vs severe immune-related toxicities
  • The art of balancing and tapering low-dose and high-dose corticosteroids
  • Differentiating between immune-related and chemotherapy- or targeted therapy–associated adverse events for optimal management approaches
  • Involvement of multidisciplinary teams early during treatment to prevent immune-related adverse events
  • Importance of educating patients, caregivers, and providers on immune-related toxicities


Presenters: 

Alexa Basilio, PharmD, BCOP
University of Florida College of Pharmacy 
Oncology Pharmacy Specialist 
McKesson, The US Oncology Network
Tampa, Florida 

Jessica Davis, PharmD, BCOP, CPP 
Levine Cancer Institute
Clinical Pharmacist Coordinator, Adult Hematology/Oncology
Atrium Health Levine Center
Charlotte, North Carolina 

Link to full program: 
https://bit.ly/3We4HJy


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör ProCE. Innehållet i podden är skapat av ProCE och inte av, eller tillsammans med, Poddtoppen.